As of 2024-12-12, the Intrinsic Value of Oasmia Pharmaceutical AB (OASM.ST) is (3,557.60) Oasmia Pharmaceutical. This OASM.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.69 Oasmia Pharmaceutical, the upside of Oasmia Pharmaceutical AB is -121,935.50%.

The range of the Intrinsic Value is (40,496.72) - (1,834.11) Oasmia Pharmaceutical

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(40,496.72) - (1,834.11)	(3,557.60)	-121935.5%
DCF (Growth 10y)	(24,002,584.33) - (637,781,840.05)	(51,025,715.37)	-1747456105.8%
DCF (EBITDA 5y)	(1,566.30) - (2,678.79)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(20,777,545.29) - (42,828,974.54)	(1,234.50)	-123450.0%
P/E	(7.77) - (14.26)	(7.27)	-348.8%
EV/EBITDA	(4.48) - (6.81)	(5.72)	-295.9%
EPV	16.07 - 28.36	22.22	660.9%
DDM - Stable	(4.36) - (208.93)	(106.65)	-3752.2%
DDM - Multi	(1,222.51) - (47,754.53)	(2,439.90)	-83658.4%